Personalized Medicine and Genomics

An emerging model of health care delivery that uses genetic information to customize a patient’s treatment.

The FDA, 23andMe, And What We Really Want From Genetic Testing

Nov. 27, 2013

In a harshly worded letter released Monday, the Food and Drug Administration (FDA) ordered the company 23andMe to “immediately discontinue marketing” its saliva spit test (from which a consumer’s DNA is isolated) and personalized genome service until it provides the FDA with requested information on safety and effectiveness. I asked Reed Pyeritz, MD, PhD, a medical geneticist at Penn and former president of the American College of Medical Genetics, to comment on this development. He wrote:

Pages